Ironwood Pharmaceuticals Inc
IRWD
$3.77+4.72%
End of day · as of Oct 16, 2026, 8:16 AM ET
Mkt cap
$579.44M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2026-06-30)
$113.04M
EPS (H1 2026)
$0.55
Gross Margin (qtr ended 2026-06-30)
N/A
Profit Margin (qtr ended 2026-06-30)
45.37%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported IRWD revenue for 2026-06-30 was $113.0M. Net income was $51.3M. Revenue was up 6.1% from 2026-03-31 to 2026-06-30. IRWD currently screens at market cap $579.4M.
Use this IRWD research hub for sector, financials, and filings — not a live tape.
Each line names its own latest cached period. Full IRWD income, balance, and cash tables.
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company in the Healthcare sector.
Latest cached Ironwood Pharmaceuticals Inc (IRWD) revenue for Jun 30, 2026 was $113.0M. Net income was $51.3M. Statements: https://lician.com/financials/irwd
Ironwood Pharmaceuticals Inc (IRWD) market capitalization is $579.4M on the latest cached snapshot.
Ironwood Pharmaceuticals Inc (IRWD) cached previous close $3.60; day range $3.66 – $3.77; volume 2,030,704. Session quote: https://lician.com/quote/irwd
Ironwood Pharmaceuticals Inc (IRWD) latest cached earnings event is "IRWD earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached IRWD filing is 8-K · Oct 16, 2026. Filings: https://lician.com/sec/irwd